| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.91e-05 | 188 | 59 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 2.09e-05 | 55 | 59 | 4 | GO:0017046 | |
| GeneOntologyMolecularFunction | vasoactive intestinal polypeptide receptor activity | 2.57e-05 | 3 | 59 | 2 | GO:0004999 | |
| GeneOntologyMolecularFunction | hormone binding | 2.44e-04 | 103 | 59 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 6.45e-04 | 133 | 59 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 7.81e-04 | 140 | 59 | 4 | GO:0001653 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | THSD4 ADAMTS19 ZNF469 FN1 HMCN1 ADAMTS9 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.34e-06 | 377 | 60 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | THSD4 ADAMTS19 ZNF469 FN1 HMCN1 ADAMTS9 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.37e-06 | 378 | 60 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | THSD4 ADAMTS19 ZNF469 FN1 HMCN1 ADAMTS9 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.40e-06 | 379 | 60 | 9 | GO:0045229 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.89e-05 | 286 | 60 | 7 | GO:0007188 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 ADAMTS19 MXRA5 ANGPT2 FN1 HMCN1 ADAMTS9 WNT3 SPON1 MUC5B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 5.66e-09 | 656 | 62 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 ADAMTS19 MXRA5 ANGPT2 FN1 HMCN1 ADAMTS9 WNT3 SPON1 MUC5B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 5.88e-09 | 658 | 62 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.64e-04 | 530 | 62 | 8 | GO:0062023 | |
| Domain | TSP_1 | THSD4 ADAMTS19 THSD7A HMCN1 ADAMTS9 SPON1 ADGRB2 THSD7B C9 ADAMTSL3 RSPO1 ADAMTSL4 ADAMTSL2 | 1.13e-20 | 63 | 61 | 13 | PF00090 |
| Domain | TSP1 | THSD4 ADAMTS19 THSD7A HMCN1 ADAMTS9 SPON1 ADGRB2 THSD7B C9 ADAMTSL3 RSPO1 ADAMTSL4 ADAMTSL2 | 1.77e-20 | 65 | 61 | 13 | SM00209 |
| Domain | TSP1_rpt | THSD4 ADAMTS19 THSD7A HMCN1 ADAMTS9 SPON1 ADGRB2 THSD7B C9 ADAMTSL3 RSPO1 ADAMTSL4 ADAMTSL2 | 1.77e-20 | 65 | 61 | 13 | IPR000884 |
| Domain | TSP1 | THSD4 ADAMTS19 THSD7A HMCN1 ADAMTS9 SPON1 ADGRB2 THSD7B C9 ADAMTSL3 RSPO1 ADAMTSL4 ADAMTSL2 | 1.77e-20 | 65 | 61 | 13 | PS50092 |
| Domain | PLAC | 6.15e-10 | 14 | 61 | 5 | PF08686 | |
| Domain | PLAC | 3.53e-09 | 19 | 61 | 5 | PS50900 | |
| Domain | PLAC | 3.53e-09 | 19 | 61 | 5 | IPR010909 | |
| Domain | ADAM_spacer1 | 1.01e-08 | 23 | 61 | 5 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.01e-08 | 23 | 61 | 5 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.04e-06 | 24 | 61 | 4 | IPR013273 | |
| Domain | HormR | 1.24e-06 | 25 | 61 | 4 | SM00008 | |
| Domain | HRM | 1.99e-06 | 28 | 61 | 4 | PF02793 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 8.62e-06 | 40 | 61 | 4 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 8.62e-06 | 40 | 61 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 8.62e-06 | 40 | 61 | 4 | PS50227 | |
| Domain | zf-TRAF_2 | 1.05e-05 | 2 | 61 | 2 | PF15965 | |
| Domain | F-box_4 | 1.05e-05 | 2 | 61 | 2 | PF15966 | |
| Domain | Fbxo30/Fbxo40 | 1.05e-05 | 2 | 61 | 2 | IPR031890 | |
| Domain | Glyco_hormone_CN | 1.47e-05 | 15 | 61 | 3 | IPR006208 | |
| Domain | Cys_knot | 1.47e-05 | 15 | 61 | 3 | PF00007 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.12e-05 | 50 | 61 | 4 | PS00650 | |
| Domain | 7tm_2 | 2.12e-05 | 50 | 61 | 4 | PF00002 | |
| Domain | GPCR_2_VIP_rcpt_1 | 3.14e-05 | 3 | 61 | 2 | IPR001771 | |
| Domain | GPCR_2_secretin-like | 4.38e-05 | 60 | 61 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 4.38e-05 | 60 | 61 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.68e-05 | 61 | 61 | 4 | PS50261 | |
| Domain | WxxW_domain | 1.56e-04 | 6 | 61 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.56e-04 | 6 | 61 | 2 | PF13330 | |
| Domain | GPCR_2_secretin-like_CS | 1.85e-04 | 34 | 61 | 3 | IPR017983 | |
| Domain | PKD | 5.66e-04 | 11 | 61 | 2 | PS50093 | |
| Domain | PKD_dom | 5.66e-04 | 11 | 61 | 2 | IPR000601 | |
| Domain | - | 5.66e-04 | 11 | 61 | 2 | 2.60.40.670 | |
| Domain | TIL | 6.78e-04 | 12 | 61 | 2 | PF01826 | |
| Domain | Znf_TRAF | 6.78e-04 | 12 | 61 | 2 | IPR001293 | |
| Domain | C8 | 6.78e-04 | 12 | 61 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 8.00e-04 | 13 | 61 | 2 | IPR014853 | |
| Domain | C8 | 8.00e-04 | 13 | 61 | 2 | SM00832 | |
| Domain | ZF_TRAF | 8.00e-04 | 13 | 61 | 2 | PS50145 | |
| Domain | TIL_dom | 9.31e-04 | 14 | 61 | 2 | IPR002919 | |
| Domain | - | 9.31e-04 | 14 | 61 | 2 | 3.90.890.10 | |
| Domain | SIAH-type | 1.22e-03 | 16 | 61 | 2 | IPR013323 | |
| Domain | VWD | 1.22e-03 | 16 | 61 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.22e-03 | 16 | 61 | 2 | IPR001846 | |
| Domain | VWFD | 1.22e-03 | 16 | 61 | 2 | PS51233 | |
| Domain | VWD | 1.22e-03 | 16 | 61 | 2 | PF00094 | |
| Domain | CTCK_1 | 1.55e-03 | 18 | 61 | 2 | PS01185 | |
| Domain | Growth_fac_rcpt_ | 1.69e-03 | 156 | 61 | 4 | IPR009030 | |
| Domain | VWC_out | 1.73e-03 | 19 | 61 | 2 | SM00215 | |
| Domain | CT | 2.32e-03 | 22 | 61 | 2 | SM00041 | |
| Domain | TRAF-like | 2.77e-03 | 24 | 61 | 2 | IPR008974 | |
| Domain | Cys_knot_C | 3.00e-03 | 25 | 61 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.00e-03 | 25 | 61 | 2 | PS01225 | |
| Domain | VWC | 3.76e-03 | 28 | 61 | 2 | PF00093 | |
| Domain | VWFC_1 | 6.15e-03 | 36 | 61 | 2 | PS01208 | |
| Domain | Ion_trans_dom | 6.16e-03 | 114 | 61 | 3 | IPR005821 | |
| Domain | Ion_trans | 6.16e-03 | 114 | 61 | 3 | PF00520 | |
| Domain | VWC | 6.84e-03 | 38 | 61 | 2 | SM00214 | |
| Domain | VWFC_2 | 6.84e-03 | 38 | 61 | 2 | PS50184 | |
| Domain | Peptidase_M12B_N | 7.19e-03 | 39 | 61 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 7.19e-03 | 39 | 61 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 7.56e-03 | 40 | 61 | 2 | PS00427 | |
| Domain | Reprolysin | 7.56e-03 | 40 | 61 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 7.56e-03 | 40 | 61 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.56e-03 | 40 | 61 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 7.56e-03 | 40 | 61 | 2 | IPR001590 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | THSD4 ADAMTS19 THSD7A ADAMTS9 SPON1 MUC5B THSD7B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 9.54e-17 | 68 | 44 | 11 | M27303 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD4 ADAMTS19 THSD7A ADAMTS9 SPON1 THSD7B ADAMTSL3 ADAMTSL4 ADAMTSL2 | 2.32e-15 | 39 | 44 | 9 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | THSD4 ADAMTS19 THSD7A ADAMTS9 SPON1 THSD7B ADAMTSL3 ADAMTSL4 ADAMTSL2 | 2.32e-15 | 39 | 44 | 9 | MM15165 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD4 ADAMTS19 THSD7A ADAMTS9 SPON1 MUC5B THSD7B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 2.19e-14 | 109 | 44 | 11 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD4 ADAMTS19 THSD7A ADAMTS9 SPON1 MUC5B THSD7B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 2.68e-14 | 111 | 44 | 11 | M27416 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | THSD4 ADAMTS19 THSD7A ADAMTS9 SPON1 MUC5B THSD7B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 4.57e-13 | 143 | 44 | 11 | M27275 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THSD4 ADAMTS19 THSD7A ADAMTS9 SPON1 MUC5B THSD7B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 2.00e-10 | 250 | 44 | 11 | M27554 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | THSD4 ADAMTS19 FBXO40 RNF7 DCAF4L2 IGFBP1 THSD7A FN1 ADAMTS9 SPON1 MUC5B THSD7B ADAMTSL3 MUC5AC ADAMTSL4 DCAF4L1 FBXO30 ADAMTSL2 LRRC41 | 8.47e-09 | 1389 | 44 | 19 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | THSD4 ADAMTS19 FBXO40 RNF7 IGFBP1 THSD7A FN1 ADAMTS9 SPON1 MUC5B THSD7B ADAMTSL3 MUC5AC ADAMTSL4 FBXO30 ADAMTSL2 LRRC41 | 8.57e-07 | 1475 | 44 | 17 | M19806 |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 5.04e-06 | 143 | 44 | 6 | MM15055 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 8.63e-06 | 157 | 44 | 6 | M4904 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.05e-05 | 94 | 44 | 5 | M797 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.54e-05 | 60 | 44 | 4 | MM14964 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 5.49e-05 | 24 | 44 | 3 | M39643 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 5.49e-05 | 24 | 44 | 3 | MM15992 | |
| Pathway | REACTOME_NEDDYLATION | 6.74e-05 | 226 | 44 | 6 | MM15543 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 7.02e-05 | 26 | 44 | 3 | M27483 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.45e-04 | 33 | 44 | 3 | MM15066 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.45e-04 | 33 | 44 | 3 | M10322 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.11e-03 | 16 | 44 | 2 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.26e-03 | 17 | 44 | 2 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.93e-03 | 21 | 44 | 2 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.31e-03 | 23 | 44 | 2 | M556 | |
| Pubmed | THSD4 ADAMTS19 THSD7A HMCN1 ADAMTS9 WNT3 SPON1 ADGRB2 THSD7B ADAMTSL3 ADAMTSL4 ADAMTSL2 | 9.81e-21 | 75 | 63 | 12 | 20637190 | |
| Pubmed | 6.74e-07 | 10 | 63 | 3 | 15670850 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 7513696 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 34058148 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 3.23e-06 | 2 | 63 | 2 | 14988081 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15563276 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17621824 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24317696 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22391959 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 3.23e-06 | 2 | 63 | 2 | 35776514 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24327612 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 3.23e-06 | 2 | 63 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 3.23e-06 | 2 | 63 | 2 | 36427316 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 32345553 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18488137 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 3.23e-06 | 2 | 63 | 2 | 28607090 | |
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 3.23e-06 | 2 | 63 | 2 | 23272068 | |
| Pubmed | Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. | 3.23e-06 | 2 | 63 | 2 | 11930171 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 3.23e-06 | 2 | 63 | 2 | 27729120 | |
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 3.23e-06 | 2 | 63 | 2 | 23527003 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 16540890 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 36111525 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 3.23e-06 | 2 | 63 | 2 | 27845589 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 27435107 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 26871672 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 3.23e-06 | 2 | 63 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 3.23e-06 | 2 | 63 | 2 | 11587997 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 3.23e-06 | 2 | 63 | 2 | 24332705 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 3.23e-06 | 2 | 63 | 2 | 34656442 | |
| Pubmed | 5.72e-06 | 64 | 63 | 4 | 22261194 | ||
| Pubmed | 8.19e-06 | 70 | 63 | 4 | 12036966 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 37957805 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 27776277 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 29286856 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 36675209 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 29802623 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 26057585 | ||
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 9.68e-06 | 3 | 63 | 2 | 34158522 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 9.68e-06 | 3 | 63 | 2 | 29604272 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 36430275 | ||
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 9.68e-06 | 3 | 63 | 2 | 19596978 | |
| Pubmed | Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. | 9.68e-06 | 3 | 63 | 2 | 8390245 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 14667842 | ||
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 9.68e-06 | 3 | 63 | 2 | 19556605 | |
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 9.68e-06 | 3 | 63 | 2 | 21455588 | |
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 9.68e-06 | 3 | 63 | 2 | 20422702 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20026142 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 19718741 | ||
| Pubmed | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. | 1.93e-05 | 4 | 63 | 2 | 31582416 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 25638393 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 17471237 | ||
| Pubmed | MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. | 1.93e-05 | 4 | 63 | 2 | 21097527 | |
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 1.93e-05 | 4 | 63 | 2 | 22269464 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 14984930 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 23249391 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.93e-05 | 4 | 63 | 2 | 29869461 | |
| Pubmed | Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. | 1.93e-05 | 4 | 63 | 2 | 18258655 | |
| Pubmed | IL-6 and PACAP receptor expression and localization after global brain ischemia in mice. | 1.93e-05 | 4 | 63 | 2 | 22669509 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 23807779 | ||
| Pubmed | Novel receptor partners and function of receptor activity-modifying proteins. | 1.93e-05 | 4 | 63 | 2 | 12446722 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 12676567 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 3.22e-05 | 5 | 63 | 2 | 11062147 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 12417650 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 29758265 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 20449688 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 3.22e-05 | 5 | 63 | 2 | 16188033 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 25237190 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 19110483 | ||
| Pubmed | PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells. | 4.82e-05 | 6 | 63 | 2 | 17115416 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 22700375 | ||
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 30738849 | ||
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 7525452 | ||
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 26245956 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 24429156 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 1.76e-04 | 11 | 63 | 2 | 36792666 | |
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 33909046 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.98e-04 | 62 | 63 | 3 | 28344315 | |
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 30146491 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 20808825 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 26405179 | ||
| Pubmed | RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6. | 2.11e-04 | 12 | 63 | 2 | 29769720 | |
| Pubmed | 2.82e-04 | 497 | 63 | 6 | 23414517 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 22797898 | ||
| Pubmed | Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome. | 2.90e-04 | 14 | 63 | 2 | 27687499 | |
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 19233133 | ||
| Pubmed | Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. | 4.32e-04 | 17 | 63 | 2 | 9175833 | |
| Pubmed | SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development. | 4.32e-04 | 17 | 63 | 2 | 27234298 | |
| Pubmed | 4.85e-04 | 200 | 63 | 4 | 18240029 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.85e-04 | 18 | 63 | 2 | 18834073 | |
| Pubmed | 4.85e-04 | 18 | 63 | 2 | 31582413 | ||
| Pubmed | 4.85e-04 | 18 | 63 | 2 | 15601820 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 4.85e-04 | 18 | 63 | 2 | 35503090 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.16e-04 | 363 | 63 | 5 | 14691545 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.21e-04 | 86 | 63 | 3 | 28327460 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 5.31e-04 | 1031 | 63 | 8 | 16710414 | |
| Pubmed | Genome-wide association study of liver enzymes in korean children. | 5.41e-04 | 19 | 63 | 2 | 24124411 | |
| Pubmed | 6.25e-04 | 214 | 63 | 4 | 22199357 | ||
| Cytoband | 12q14.1 | 6.85e-04 | 28 | 63 | 2 | 12q14.1 | |
| GeneFamily | ADAMTS like | 9.65e-10 | 7 | 43 | 4 | 947 | |
| GeneFamily | Vasoactive intestinal peptide receptor family | 1.66e-05 | 3 | 43 | 2 | 264 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 9.21e-04 | 19 | 43 | 2 | 50 | |
| GeneFamily | CD molecules|Mucins | 1.13e-03 | 21 | 43 | 2 | 648 | |
| GeneFamily | WD repeat domain containing | 3.41e-03 | 262 | 43 | 4 | 362 | |
| GeneFamily | Cyclins|F-boxes other | 3.87e-03 | 39 | 43 | 2 | 560 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.59e-03 | 161 | 43 | 3 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.08e-02 | 193 | 43 | 3 | 594 | |
| GeneFamily | Endogenous ligands | 1.87e-02 | 237 | 43 | 3 | 542 | |
| Coexpression | NABA_MATRISOME | THSD4 ADAMTS19 MXRA5 IGFBP1 ANGPT2 FN1 HMCN1 ADAMTS9 CLEC4A WNT3 SPON1 MUC5B ADAMTSL3 RSPO1 MUC5AC ADAMTSL4 ADAMTSL2 | 1.47e-10 | 1026 | 62 | 17 | M5889 |
| Coexpression | NABA_MATRISOME | THSD4 ADAMTS19 IGFBP1 ANGPT2 FN1 HMCN1 ADAMTS9 CLEC4A WNT3 SPON1 MUC5B ADAMTSL3 RSPO1 MUC5AC ADAMTSL4 ADAMTSL2 | 1.05e-09 | 1008 | 62 | 16 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.08e-07 | 196 | 62 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 3.90e-06 | 275 | 62 | 7 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.06e-06 | 191 | 62 | 6 | MM17059 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 ANGPT2 ADAMTS9 CLEC4A WNT3 MUC5B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 8.44e-06 | 738 | 62 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 ANGPT2 ADAMTS9 CLEC4A WNT3 MUC5B ADAMTSL3 MUC5AC ADAMTSL4 ADAMTSL2 | 9.83e-06 | 751 | 62 | 10 | M5885 |
| Coexpression | NABA_CORE_MATRISOME | 4.28e-05 | 270 | 62 | 6 | MM17057 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | ZACN RAMP1 IGFBP1 NDRG1 KCNC2 SPON1 ADGRB2 CDC20B SCTR RSPO1 SEZ6 | 5.44e-05 | 1115 | 62 | 11 | M10371 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 9.93e-05 | 195 | 62 | 5 | M45684 | |
| Coexpression | AIZARANI_LIVER_C17_HEPATOCYTES_3 | 1.01e-04 | 102 | 62 | 4 | M39119 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_DN | 1.12e-04 | 200 | 62 | 5 | M4818 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 1.44e-04 | 211 | 62 | 5 | M12225 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.83e-04 | 352 | 62 | 6 | M17471 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 1.96e-04 | 9 | 62 | 2 | MM888 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 1.96e-04 | 9 | 62 | 2 | M2187 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ADAMTS19 VIPR1 NDRG1 FN1 HMCN1 SPON1 ADGRB2 THSD7B RSPO1 PEAR1 | 1.98e-04 | 1074 | 62 | 10 | M1941 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 4.26e-06 | 439 | 61 | 9 | GSM777059_500 | |
| CoexpressionAtlas | endometrium | 1.99e-05 | 115 | 61 | 5 | endometrium | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 3.89e-05 | 445 | 61 | 8 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 4.55e-05 | 455 | 61 | 8 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.38e-05 | 466 | 61 | 8 | GSM777050_500 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 8.08e-09 | 185 | 63 | 7 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 8.08e-09 | 185 | 63 | 7 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 8.70e-09 | 187 | 63 | 7 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-08 | 191 | 63 | 7 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-08 | 200 | 63 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-07 | 182 | 63 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 2.34e-07 | 183 | 63 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.65e-07 | 187 | 63 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 192 | 63 | 6 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 3.20e-07 | 193 | 63 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.20e-07 | 193 | 63 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 3.40e-07 | 195 | 63 | 6 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-07 | 195 | 63 | 6 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.40e-07 | 195 | 63 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-07 | 197 | 63 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-07 | 198 | 63 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.71e-07 | 198 | 63 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.71e-07 | 198 | 63 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.82e-07 | 199 | 63 | 6 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-07 | 199 | 63 | 6 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-07 | 199 | 63 | 6 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.94e-07 | 200 | 63 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.94e-07 | 200 | 63 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.94e-07 | 200 | 63 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.39e-07 | 119 | 63 | 5 | d8fbea9ded96fcc3ebdfb4d28873c563427ce811 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.39e-07 | 119 | 63 | 5 | 9e38f13bf98b9ee44b178300e6f80fd08a006296 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.15e-06 | 130 | 63 | 5 | 0219d0d5d21df08f816569c7eb34f1bfa095d29a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-06 | 169 | 63 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 176 | 63 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 5.06e-06 | 176 | 63 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 176 | 63 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 5.06e-06 | 176 | 63 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.20e-06 | 177 | 63 | 5 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.50e-06 | 179 | 63 | 5 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 180 | 63 | 5 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 5.80e-06 | 181 | 63 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-06 | 181 | 63 | 5 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 5.96e-06 | 182 | 63 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 6.12e-06 | 183 | 63 | 5 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 183 | 63 | 5 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 6.45e-06 | 185 | 63 | 5 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 6.45e-06 | 185 | 63 | 5 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 6.62e-06 | 186 | 63 | 5 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.80e-06 | 187 | 63 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.80e-06 | 187 | 63 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 189 | 63 | 5 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 7.16e-06 | 189 | 63 | 5 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 189 | 63 | 5 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-06 | 189 | 63 | 5 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.16e-06 | 189 | 63 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 7.16e-06 | 189 | 63 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 189 | 63 | 5 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 7.16e-06 | 189 | 63 | 5 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.34e-06 | 190 | 63 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.53e-06 | 191 | 63 | 5 | 9431ffd6b758f756609d9057de2023596e22b5d4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 191 | 63 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 191 | 63 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.72e-06 | 192 | 63 | 5 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-06 | 192 | 63 | 5 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-06 | 192 | 63 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 7.72e-06 | 192 | 63 | 5 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-06 | 192 | 63 | 5 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.72e-06 | 192 | 63 | 5 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-06 | 192 | 63 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-06 | 192 | 63 | 5 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-06 | 192 | 63 | 5 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.72e-06 | 192 | 63 | 5 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-06 | 192 | 63 | 5 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.92e-06 | 193 | 63 | 5 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-06 | 193 | 63 | 5 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.92e-06 | 193 | 63 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.92e-06 | 193 | 63 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.92e-06 | 193 | 63 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.92e-06 | 193 | 63 | 5 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.92e-06 | 193 | 63 | 5 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.92e-06 | 193 | 63 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.92e-06 | 193 | 63 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 7.92e-06 | 193 | 63 | 5 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.92e-06 | 193 | 63 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.92e-06 | 193 | 63 | 5 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.92e-06 | 193 | 63 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.12e-06 | 194 | 63 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.12e-06 | 194 | 63 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 8.12e-06 | 194 | 63 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.12e-06 | 194 | 63 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.12e-06 | 194 | 63 | 5 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-06 | 194 | 63 | 5 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.33e-06 | 195 | 63 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 195 | 63 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.33e-06 | 195 | 63 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.33e-06 | 195 | 63 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 195 | 63 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.33e-06 | 195 | 63 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.33e-06 | 195 | 63 | 5 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.33e-06 | 195 | 63 | 5 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.54e-06 | 196 | 63 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.54e-06 | 196 | 63 | 5 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.54e-06 | 196 | 63 | 5 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.54e-06 | 196 | 63 | 5 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.54e-06 | 196 | 63 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| Drug | AC1L4RIC | 1.92e-07 | 5 | 62 | 3 | CID000162562 | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.51e-05 | 195 | 62 | 6 | 6104_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 4625_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 6059_UP | |
| Disease | intraocular pressure measurement | 9.80e-06 | 509 | 61 | 8 | EFO_0004695 | |
| Disease | COVID-19 symptoms measurement | 5.25e-05 | 35 | 61 | 3 | EFO_0600019 | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 1.73e-04 | 52 | 61 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 1.87e-04 | 10 | 61 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | pulmonary fibrosis | 2.28e-04 | 11 | 61 | 2 | EFO_0009448 | |
| Disease | interstitial lung disease | 3.66e-04 | 67 | 61 | 3 | EFO_0004244 | |
| Disease | glycerate measurement | 4.34e-04 | 15 | 61 | 2 | EFO_0021029 | |
| Disease | Age-related macular degeneration | 6.30e-04 | 18 | 61 | 2 | cv:C0242383 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.19e-04 | 195 | 61 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 8.61e-04 | 21 | 61 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | tooth agenesis | 9.46e-04 | 22 | 61 | 2 | EFO_0005410 | |
| Disease | congestive heart failure (is_implicated_in) | 1.43e-03 | 27 | 61 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | opioid dependence | 1.48e-03 | 237 | 61 | 4 | EFO_0005611 | |
| Disease | Malignant mesothelioma | 1.51e-03 | 109 | 61 | 3 | C0345967 | |
| Disease | Age related macular degeneration | 1.76e-03 | 30 | 61 | 2 | C0242383 | |
| Disease | adult onset asthma | 1.89e-03 | 118 | 61 | 3 | EFO_1002011 | |
| Disease | cortical thickness | 2.00e-03 | 1113 | 61 | 8 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSMAACPVEGQWLEW | 411 | O60241 | |
| CDMGPCTTAWFHSDW | 836 | Q6UY14 | |
| KCSQMLTGGWWFDAC | 436 | O15123 | |
| SWFVCNRIHCPNMTW | 441 | P23109 | |
| TMGCEPQCAWSEWLD | 2311 | Q9HC84 | |
| VVTMGCEPQCAWSEW | 2866 | Q9HC84 | |
| NAVAMWSWDVECDTC | 36 | Q9UBF6 | |
| DCTWHMAEKLGCFWP | 71 | O60894 | |
| CMTVWEAGVWSECSV | 1036 | Q8TE59 | |
| WGIDETDVEPCCWMT | 141 | Q96PR1 | |
| NLEAKMGPCWWESGT | 1446 | Q9BY89 | |
| QDSACHVFWWLEGMC | 91 | Q8IZA0 | |
| MLCSFQIPEAWSCAW | 176 | Q3SXM0 | |
| MLCSFQIPDAWSCAW | 176 | Q8NA75 | |
| MDGEAGLCWCVYPWN | 221 | P08833 | |
| WRGDDCSSECAPGMW | 126 | Q5VY43 | |
| NPCAEGWMDWAASKI | 166 | Q92597 | |
| GPQWEMSEWSECTAK | 686 | Q86TH1 | |
| WMWPGKDAAALTICC | 6 | O75949 | |
| PVCGEKCLWSPWMDV | 1381 | P98088 | |
| SRAVWEEMVNACWCG | 546 | Q7Z3U7 | |
| SPGCPGMWDNITCWK | 51 | P41586 | |
| CNTDMCPVDGSWGSW | 4806 | Q96RW7 | |
| SWADCPISGHMWEFT | 471 | Q8TCG5 | |
| VTPCGQWKALDWSSC | 1236 | Q9P2N4 | |
| WITGEWSECSVTCGK | 1616 | Q9P2N4 | |
| TTDACWGRCETWEKP | 56 | Q86YW7 | |
| WEKPYQGWMMVDCTC | 201 | P02751 | |
| SVVCCSMEWNRWPNV | 91 | Q9UH90 | |
| STAVKAMDWCPWQSG | 401 | Q86Y33 | |
| GLACCWSIKNPMWPE | 516 | Q5VTH9 | |
| ACTFGDMCCWWVGPW | 81 | Q08477 | |
| LWEGWPTSATDDSMC | 236 | Q9UNN5 | |
| SVVCCTMEWNRWPVS | 86 | Q8TB52 | |
| TWVKQCWSVAACPEE | 236 | Q96MH7 | |
| TGEACWWTMHPASKQ | 141 | P21817 | |
| WAMIWDFTEPVCRGC | 26 | Q7Z5L9 | |
| MPTSETSWWPGACLC | 1 | Q6W349 | |
| IDCRMSPWSEWSQCD | 41 | P02748 | |
| WCNSSRSEPCLMDWR | 661 | P42702 | |
| HPNFWMDGKWRCCSQ | 121 | Q08881 | |
| CDDWYHWPCVGIMTA | 886 | Q5VWG9 | |
| EWITWSPCSISCGMG | 506 | Q9HCB6 | |
| PSSCLMTEWGEWDEC | 556 | Q9HCB6 | |
| EWLPSQESSAGCKWM | 96 | Q6NUJ1 | |
| WSEWSPCSKTCHDMV | 366 | Q9UPZ6 | |
| MAAPEAWRARSCWFC | 1 | Q15345 | |
| AQCEMSEWSPWGPCS | 146 | Q2MKA7 | |
| PECDWWSLGVCMYEM | 261 | Q5VT25 | |
| MPVEETAWSCCPKNW | 96 | Q9UMR7 | |
| EWTWKNCSGEMPFIS | 506 | Q7Z3I7 | |
| ASPGWTCWECDCLFM | 1021 | Q9HCE3 | |
| IGCSKMWDNLTCWPA | 61 | P32241 | |
| CEGMWDNISCWPSSV | 66 | P47872 | |
| LSGSCEVKTCWWAQP | 211 | P56703 | |
| MCQWDLTWSEDLPSC | 751 | Q53EL9 | |
| SFCICDGTVWTKVGW | 21 | A0A1B0GTY4 | |
| MLVTLFSAWHWCPCS | 246 | Q9P0V8 | |
| PWACGMCLKEVADVW | 3146 | Q96JG9 | |
| AGIWMWAACKSDAAP | 386 | Q401N2 | |
| SVWVTAADCWMCQPV | 106 | Q8N3G9 | |
| ETLWDCMEVAGQSWC | 691 | Q01118 | |
| CIMPKDCETSQWSSW | 331 | Q9C0I4 | |
| IPCRMDCVLSEWTEW | 596 | Q9C0I4 | |
| NECVMSEWGLWSKCP | 1126 | Q9C0I4 | |
| CPAFWDIGEWSECSK | 676 | Q6ZMP0 | |
| KWIAMEWSQCTVTCG | 481 | P82987 | |
| GNPWTCDCEMRWFLE | 216 | Q9NR99 |